Oren Gilad

Companies

• Aprea Therapeutics, Inc.Chief executive officer Aug 1, 2022 to now¹
• Aprea Therapeutics, Inc.Board member May 26, 2022 to now²
• Aprea Therapeutics, Inc.President May 26, 2022 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAprea Therapeutics, Inc. APRE394,495 shares³$222.8K at $0.56Mar 16, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 12, 2026Granted 20,175 shares of Aprea Therapeutics, Inc.³
• Jan 30, 2026Bought 28,100 shares at $0.89 of Aprea Therapeutics, Inc.⁴
• Apr 3, 2025Bought 2,497 shares at $1.80 of Aprea Therapeutics, Inc.⁵
• Apr 3, 2025Bought 3,003 shares at $1.87 of Aprea Therapeutics, Inc.⁵
• Mar 27, 2025Granted 6,725 shares of Aprea Therapeutics, Inc.⁶
• Oct 23, 2024Bought 500 shares at $3.92 of Aprea Therapeutics, Inc.⁷
• Oct 15, 2024Bought 250 shares at $2.90 of Aprea Therapeutics, Inc.⁸
• Oct 14, 2024Bought 1,000 shares at $2.59 of Aprea Therapeutics, Inc.⁹
• Oct 10, 2024Bought 150 shares at $2.54 of Aprea Therapeutics, Inc.⁹
• Mar 28, 2024Granted 6,725 shares of Aprea Therapeutics, Inc.¹⁰
• Mar 13, 2024Bought 2,000 shares at $7.29 of Aprea Therapeutics, Inc.¹¹
• Mar 9, 2023Granted 4,000 shares of Aprea Therapeutics, Inc.¹²
• Aug 23, 2022Converted 6,045,100 shares of Aprea Therapeutics, Inc.¹²
• Jul 28, 2022Granted 101,300 shares of Aprea Therapeutics, Inc.¹³